Insider · CIK 0001824863

Fisher Stewart

Reports to the SEC for 1 company · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001824863

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-09-16	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,250 sh	—	—	131,371
2024-09-16	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−661 sh	$6.36	−$4,203.96	130,710
2024-09-16	CCCCC4 Therapeutics, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,250 sh	—	—	14,250
2024-03-07	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−95K sh	—	—	0
2024-03-07	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+95K sh	—	—	94,950
2024-03-07	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−118K sh	—	—	0
2024-03-07	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+118K sh	—	—	118,000
2024-02-14	CCCCC4 Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+27.3K sh	—	—	129,121
2024-02-14	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+123K sh	—	—	122,800
2024-02-13	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−2,255 sh	$6.53	−$14.7K	101,821
2023-09-18	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+120K sh	—	—	120,000
2023-08-30	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,250 sh	—	—	104,737
2023-08-30	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−661 sh	$2.93	−$1,936.73	104,076
2023-08-30	CCCCC4 Therapeutics, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,250 sh	—	—	16,500
2023-02-13	CCCCC4 Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+26K sh	—	—	102,487
2023-02-13	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+125K sh	—	—	125,000
2023-01-30	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,750 sh	—	—	77,788
2023-01-30	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,301 sh	$7.78	−$10.1K	76,487
2023-01-30	CCCCC4 Therapeutics, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,750 sh	—	—	18,750
2022-05-26	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,102 sh	$7.01	−$7,725.02	74,038
2022-05-25	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,750 sh	—	—	75,140
2022-05-25	CCCCC4 Therapeutics, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,750 sh	—	—	22,500
2022-04-12	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,156 sh	$3.71	+$7,998.76	45,462
2022-04-12	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+25.9K sh	$4.98	+$129K	71,390
2022-04-12	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,156 sh	—	—	35,572
2022-04-12	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−25.9K sh	—	—	48,152
2022-02-14	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+118K sh	—	—	118,000
2022-02-14	CCCCC4 Therapeutics, Inc. · Performance Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+26.3K sh	—	—	26,250
2021-12-08	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,373 sh	$2.11	+$5,007.03	25,117
2021-12-08	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+17.8K sh	$3.71	+$66K	42,903
2021-12-08	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+403 sh	$4.98	+$2,006.94	43,306
2021-12-08	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,373 sh	—	—	0
2021-12-08	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−17.8K sh	—	—	37,728
2021-12-08	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−403 sh	—	—	203,994
2021-08-03	CCCCC4 Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−17.1K sh	$45.01	−$768K	22,744
2021-08-02	CCCCC4 Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−18.1K sh	$45.00	−$815K	39,801
2021-07-29	CCCCC4 Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−50.2K sh	$45.00	−$2.26M	57,905
2021-02-11	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+95K sh	—	—	94,950
2021-02-03	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,371 sh	$2.11	+$5,002.81	102,187
2021-02-03	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,929 sh	$3.71	+$22K	108,116
2021-02-03	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,371 sh	—	—	2,371
2021-02-03	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,929 sh	—	—	55,514
2020-12-11	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,743 sh	$2.11	+$10K	90,115
2020-12-11	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+9,701 sh	$3.71	+$36K	99,816
2020-12-11	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,743 sh	—	—	4,742
2020-12-11	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−9,701 sh	—	—	61,443

Recent filings

Accepted (ET)
Sep 174
Fisher Stewart0001662579-24-000081
SEC(opens sec.gov)
Mar 84
Fisher Stewart0001662579-24-000030
SEC(opens sec.gov)
Feb 154
Fisher Stewart0001662579-24-000016
SEC(opens sec.gov)
Sep 194
Fisher Stewart0001662579-23-000100
SEC(opens sec.gov)
Aug 314
Fisher Stewart0001662579-23-000082
SEC(opens sec.gov)
Feb 154
Fisher Stewart0001662579-23-000039
SEC(opens sec.gov)
Feb 14
Fisher Stewart0001662579-23-000018
SEC(opens sec.gov)
Jun 144/A
Fisher Stewart0001209191-22-036715
SEC(opens sec.gov)

Companies

C4 Therapeutics, Inc.Chief Scientific OfficerCCCC

Address

C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 200

WATERTOWN, MA, 02472